Retinoblastomas initiate in the developing retina in utero and are diagnosed during the first few years of life. We have recently generated a series of knockout mouse models of retinoblastoma that recapitulate the timing, location, and progression of human retinoblastoma. One of the most important benefits of these preclinical models is that we can study the earliest stages of tumor initiation and expansion. This is not possible in human retinoblastoma because tumors initiate in utero and are not diagnosed until they are at an advanced stage. We found that mouse retinoblastoma cells exhibit a surprising degree of differentiation, which has not been previously reported for any neural tumor. Early-stage mouse retinoblastoma cells express proteins found normally in retinal plexiform layers. They also extend neurites and form synapses. All of these features, which were characterized by immunostaining, Golgi-Cox staining, scanning electron microscopy, and transmission electron microscopy, suggest that mouse retinoblastoma cells resemble amacrine/horizontal cells from the retina. As late-stage retinoblastoma cells expand and invade the surrounding tissue, they lose their differentiated morphology and become indistinguishable from human retinoblastomas. Taken together, our data suggest that neuronal differentiation is a hallmark of early-stage retinoblastoma and is lost as cells become more aggressive and invasive. We also show that rosette formation is not a hallmark of retinoblastoma differentiation, as previously believed. Instead, rosette formation reflects extensive cell-cell contacts between retinoblastoma cells in both early-stage (differentiated) and latestage (dedifferentiated) tumors. [Cancer Res 2007;67(6):2701-11] 
Introduction
Mouse models of human cancer allow us to study early tumor formation and determine whether tumor cell differentiation is a hallmark of carcinogenesis. However, these models must recapitulate the histopathologic and genetic features of the human disease. We and others have generated knockout mouse models of retinoblastoma by inactivating the Rb and p107 genes in the developing mouse retina of Chx10-Cre;Rb Lox/À ;p107 À/À mice (1-4).
MacPherson et al. showed that inactivation of Rb and p130 also led to retinoblastoma in mice (2) . Although these mouse models are not the focus of this report, future analyses will compare data on the Rb;p107-deficient and Rb;p130-deficient retinoblastomas. Chx10-Cre;Rb Lox/ ;p107 À/À tumors exhibit only limited penetrance (50-60%) and minimal invasion of the surrounding tissue (5). When we simultaneously inactivated Rb, p107, and p53 in the developing Chx10-Cre;Rb Lox/À ;p53 Lox/À ;p107 À/À retina, aggressive, invasive bilateral retinoblastoma formed in 100% of the mice by a few months of age. We also recapitulated the loss of heterozygosity at the Rb locus in Chx10-Cre;Rb
Lox/+ ;p53 Lox/À ;p107 À/À mice (5, 6) .
In human retinoblastoma, the p53 gene is not mutated (7, 8) . These data suggest that the p53 pathway is inactivated in human retinoblastoma by a genetic lesion not involving the p53 locus. We recently found that amplification of the MDMX and MDM2 genes suppresses the p53 pathway in 75% of human retinoblastomas (9) . Currently, no inducible, tissue-specific MDMX transgenic mouse line is available to recapitulate MDMX amplification in mouse retinoblastoma. However, our studies have shown that MDMX acts exclusively through the p53 protein; therefore, the Chx10-Cre;Rb Lox/+ ;p53
Lox/À ;p107 À/À mice are the best mouse model of human retinoblastoma in that they recapitulate the genetic lesions in the tumor suppressor pathways (i.e., Rb and p53 pathways) and the histopathologic features of human retinoblastoma. These data, combined with the extensive characterization of the role of the retinoblastoma family in retinal development (1, 2, (10) (11) (12) , suggest that Chx10-Cre;Rb Lox/À ;p53 ;p107 À/À mouse is that Cre-mediated recombination of the Rb Lox and p53 Lox alleles occurs in a mosaic pattern of apical-basal stripes across the entire retina during development (11, 13) . Not only does this mimic the developmental environment of human retinoblastoma, which initiates in utero, but also it leads to several neoplastic foci in each retina that facilitate the characterization of early-stage retinoblastoma tumorigenesis. Unlike other retinoblastoma models that rely on Nestin-Cre (2) or Pax6-Cre (1), the mosaic pattern of Rb and p53 inactivation using Chx10-Cre minimizes the complication of non-cell autonomous effects. Specifically, the Chx10-Cre;Rb Lox/À ; p53
Lox/À ;p107 À/À mice have multiple tumor foci interspersed throughout nontransformed tissue, which permits a direct comparison of cell autonomous and non-cell autonomous effects. We analyzed the differentiation of mouse retinoblastomas by using immunostaining, real-time reverse transcription-PCR (RT-PCR), dissociated cell scoring, Golgi-Cox staining, scanning electron microscopy (SEM), and transmission electron microscopy (TEM). Although some investigators have used the term ''tumor differentiation'' to describe the progressive change in general appearance of the tumor as it assumes more neoplastic histologic features, we used a variety of morphologic assessments to define cellular differentiation (and possible dedifferentiation) during early and late stages of tumorigenesis. This rigorous assessment indicated that tumor progression reflects a changing ratio of highly differentiated and less-differentiated cell types, with the most advanced tumors composed primarily of undifferentiated cells.
Our data indicate that early-stage mouse retinoblastomas exhibit an extraordinary degree of differentiation, including neurite extension and synapse formation. This is a hallmark of early-stage tumorigenesis. As human or mouse retinoblastoma cells progress to late-stage tumorigenesis and invade the surrounding tissue, they lose their ability to differentiate. This is the first report of synaptogenesis in a central nervous system tumor and provides insight into the cell of origin, stem cell mechanism of growth, and the molecular/cellular changes that accompany tumor progression in the developing retina. These studies set the stage for analysis of other retinoblastoma models that have different gene deletions. Rb Lox/À ;p107 À/À mice has been described elsewhere (4).
Materials and Methods

Animals
Immunostaining. Retinae were freshly dissected and fixed overnight in 4% paraformaldehyde/1Â PBS. Tissue was embedded in 4% agarose, and 50-Am sections were blocked and immunostained as described previously (14, 15) . Primary antibodies and dilutions are provided in Table 2 . Biotinconjugated secondary antibodies (Vector Laboratories, Burlingame, CA) were diluted to 1:500, with the exception of mGluR6, which was diluted to 1:1,000. The Vectastain ABC reagent (Vector Laboratories) was used according to the manufacturer's instructions. Antigen detection was carried out using Cy3-tyramide (Perkin-Elmer, Wellesley, MA) according to the manufacturer's instructions. Nuclei were counterstained with SYTOX Green (Invitrogen, Carlsbad, CA) diluted to 1:15,000. All images were acquired on a Leica TCSNT confocal microscope.
Electron microscopy. Animals were anesthetized with avertin until deep tendon reflexes were lost. Transcardial perfusion was done first with carboxygenated Ames medium supplemented with 40 mmol/L glucose to clear the vasculature and then with Sorenson's phosphate buffer (pH 7.2) with 2% electron microscopy-grade paraformaldehyde and 1% electron microscopy-grade glutaraldehyde. Eyes were then harvested. A slit was made in the cornea to aid in diffusion of fixative, and the tissue was placed in Sorenson's phosphate buffer with 3% glutaraldehyde overnight. For TEM analysis, tissue was washed with 0.2 mol/L cacodylate buffer in 5% sucrose, post-fixed in 1% OsO 4 , embedded, sectioned, stained with uranyl acetate and Reynold's lead citrate, and mounted for imaging. For SEM analysis, samples were rinsed in 0.1 mol/L sodium cacodylate buffer with 5% sucrose and post-fixed in 1% OsO 4 in the same buffer for 1 h. After rinsing, the samples were stained en bloc with 4% uranyl acetate in water for 2 h and dehydrated in a graded series of ethanol solutions to a final rinse in absolute ethanol. The samples were exposed to critical point drying in a Samdri 520 system (Tousimis, Rockville, MD) and viewed using an FEI Phillips XL30 Environmental Scanning Electron Microscope.
RNA isolation, cDNA synthesis, and real-time RT-PCR. Tumors were removed from the surrounding sclera, lens, cornea, and iris and immediately flash frozen and stored at À80jC. RNA was extracted using TRIzol reagent (Invitrogen) according to the manufacturer's instructions and reverse transcribed using the SuperScript II cDNA synthesis kit (Invitrogen). Real-time RT-PCR primers and probes were designed using Primer Express software (Applied Biosystems, Foster City, CA); the probe reporter was FAM, and the quencher was BHQ. The real-time RT-PCR reactions were done in 20-AL reactions containing 200 nmol/L primers, 200 nmol/L probe, and Taqman Universal PCR Master Mix (Applied Biosystems) on an ABI 7900 HT Sequence Detection System (Applied Biosystems). The following PCR variables were used: incubation at 50jC for 2 min followed by 95 jC for 10 min and 40 cycles of 95 jC for 15 s and 60 jC for 1 min. Realtime RT-PCR data for Gapd (glyceraldehyde-3-phosphate dehydrogenase; Mm.317779) and Gpi1 (glucose phosphate isomerase; Mm.589) were used as internal references.
Golgi-Cox staining. Rapid Golgi-Cox staining was done on whole eyes by using the FD Rapid GolgiStain kit (FD NeuroTechnologies, Inc., Ellicott City, MD), as described by the manufacturer.
Immunostaining of dissociated cells. Dissociated cells were fixed in 4% paraformaldehyde in PBS, washed, and treated with 1% hydrogen peroxide in PBS before incubation in blocking solution (PBS containing 0.5% Triton X-100 and 2% normal donkey serum or 2% normal goat serum). Biotin-conjugated secondary antibodies (donkey anti-mouse IgG and goat anti-rabbit IgG) were diluted to 1:500 in blocking solution. After secondary antibody binding, the dissociated cells were incubated with an avidinbiotin-peroxidase complex (Vectastain ABC) and then detected with Cy3-tyramide (Perkin-Elmer) according to the manufacturer's instructions. For nuclear staining, dissociated cells were incubated with either SYTOX green or 4 ¶,6-diamidino-2-phenylindole (Invitrogen; 1:20,000). Labeled cells were visualized using a Zeiss Axioplan 2 microscope, and images were captured with an Axiocam digital camera (Zeiss, Thornwood, NY). (14, 15) . Detailed protocols are available online. 6 Cell viability and apoptosis. Dissociated cells or retinal sections (14-Am thick) obtained on a Leica cryostat (Leica, Bannockburn, IL) were stained using the terminal deoxynucleotidyl transferase-mediated nick-end labeling (TUNEL) apoptosis system (Promega, Madison, WI) according to the manufacturer's instructions, with the exception that we used Cy3-tyramide for detection rather than the colorimetric substrate. The TUNEL assay was complemented by staining for activated caspase-3. Stained retinal sections were imaged using a Leica TLSNT confocal microscope, and the percentage of labeled nuclei was determined from micrographs. Analysis of cell viability and Annexin staining was done by fluorescence-activated cell sorting using the Viacount kit (Guava Technologies, Hayward, CA) according to the manufacturer's instructions.
Results
Expansion of retinoblastoma into the vitreous, subretinal space, and anterior chamber. To study how retinoblastomas expand and invade the surrounding tissues, we perfused 21 mice ages postnatal day 4 (P4) to P257 ( (5, 6) . In most cases, both eyes were examined, except when one was needed for comparative genetic or confocal studies. Three eyes were bisected through the optical nerve for direct comparison (i.e., one half was used for SEM, and the other half was used for TEM).
All three genotypes showed significant disruptions in retinal morphology by P12 to P13 (Table 1; Lox/Lox ) contained an early-stage tumor with a pronounced vitreal protrusion (Fig. 1A) . In normal eyes, contiguous Müller glial cells form the inner limiting membrane (ILM), which appears as a smooth, unbroken surface on the SEM image. In diseased eyes, retinoblastoma cells ruptured the ILM, particularly near the apex of the protrusion, where tumor cells could invade the vitreous (Fig.  1B) . At these breach points, the retinoblastoma cell bodies and associated vasculature were exposed to view (Fig. 1B, enlargement  1 ). This early-stage tumor also contained structures that resembled neuronal processes (Fig. 1B , enlargement 2) similar to those found in the plexiform layers of a normal retina (Fig. 1C) . These neuritelike structures were also present in more advanced tumors but were not found in the cells that had invaded the surrounding tissue (e.g., the anterior chamber; Table 1 ; Supplementary Figs. S1 and S2).
Mouse retinoblastomas express markers of differentiated neurons. To determine whether proteins associated with retinal synapses are expressed in mouse retinoblastoma, we immunostained sections of early-stage and late-stage tumors from Chx10-Cre;Rb Lox/À ;p107 À/À ;p53 Lox/Lox mice by using antibodies that recognized proteins associated with the seven major classes of retinal cell types (Table 2) . We also included antibodies that recognize synapse-associated proteins expressed in different neuronal cell types (Table 2) . Consistent with a previous characterization of mouse retinoblastomas (16), the following proteins typically found in horizontal/amacrine cells were expressed in the mouse retinoblastoma: Calbindin ( Fig. 2A) , Syntaxin-1 ( Fig. 2B ), synapsin-1 ( Fig. 2C) , Gad65, Snap25, vGlut-1, E-cadherin, and N-cadherin ( Supplementary Fig. S3 ). The heterogeneous expression of these proteins suggests that mouse retinoblastomas contain restricted regions where tumor cells differentiation along the horizontal/amacrine cell lineage. The portions of the retinoblastomas immunonegative for amacrine/ horizontal markers contained more densely packed nuclei and lacked expression of markers for rods, cones, bipolar cells, ganglion cells, Müller glia, and astrocytes. Real-time RT-PCR was used to confirm the immunostaining results and to analyze retinal progenitor cell markers Eya2, Fgf15, and Sfrp1 ( Supplementary  Fig. S4 ). The immunostaining data suggest that mouse retinoblastomas are heterogeneous: some cells differentiate and resemble amacrine/horizontal cells, and others are less differentiated.
Based on the number of cells immunopositive for each of the amacrine/horizontal cell markers (1.7-3.1 Â 10 6 per tumor), it is unlikely that normal retinal neurons were embedded in the growing tumors. Far fewer amacrine/horizontal cells are present in the normal mouse retina (17) .
To determine whether the differentiated tumor cells proliferate or are quiescent, we injected (Fig. 3C) . The remaining cells were less differentiated with short (<1 cell body length) unbranched neurites (data not shown). Just as in the immunostained tumor sections, the Golgi-Cox-stained cells were found near the tumor origin; fewer Golgi-Cox-labeled cells were present toward the lens and anterior chamber (Fig. 3D ). This finding is consistent with the loss of the differentiated tumor phenotype as retinoblastoma cells become more invasive and aggressive. Synapse formation in mouse retinoblastoma. Retinoblastoma tumors in Chx10-Cre;Rb Lox/À ;p107 À/À mice were characterized by pronounced loss of photoreceptor cells, appearance of unique populations of undifferentiated tumor-like cells, and extensive formation of plexiform regions. Smaller tumors were more common, but in some instances, a large tumor filled much of the vitreal space (Fig. 4A) . TEM images of a Chx10-Cre;Rb Lox/À ;p107
À/À tumor revealed two morphologically distinct cell types: stage I retinoblastoma cells which had pale, round nuclei and resembled differentiated neurons (Fig. 4B) , were almost exclusively associated with a plexus. This is consistent with a differentiated tumor phenotype along amacrine/horizontal cell lineages. Stage II retinoblastoma cells contained more darkly stained, irregular nuclei and were packed tightly together with little or no plexus (Fig. 4B ). This morphology is characteristic of a less differentiated tumor cell phenotype.
Rosettes in the Chx10-Cre;Rb Lox/À ;p107 À/À retinoblastomas were usually made up of stage I cells with a central plexus but were also found adjacent to clusters of stage II cells (Fig. 4B) . TEM images of the Chx10-Cre;Rb Lox/À ;p107 À/À retinoblastoma also revealed mitotic figures and apoptotic cells, which are hallmarks of human retinoblastoma. Higher-magnification TEM images revealed that the plexus regions of Chx10-Cre;Rb Lox/À ;p107 À/À tumors not only contained processes that resembled those found in amacrine/ horizontal cells but also all of the plexus regions contained synaptic densities and associated synaptic vesicles (Fig. 4C) . These data are consistent with the immunofluorescence studies ( Fig. 2 ; Supplementary Fig. S3 ) that suggested that these retinoblastoma cells express markers found in neurites and synapses. Fig. S6A ), the anterior chamber, and the subretinal pigmented epithelium compartment (Supplementary Fig. S6B ). As in human retinoblastoma, Chx10-Cre;Rb Lox/À ;p107 À/À ;p53 Lox/Lox mice showed rapid filling of the vitreal cavity with densely packed tumor cells and rosettes ( Supplementary Fig. S6C-E) . A prominent feature of the Chx10-Cre;Rb Lox/À ;p107 À/À ;p53 Lox/Lox retinoblastomas was an overabundance of stage II cells. This finding is consistent with the hypothesis that inactivation of p53 promotes tumor progression to a less differentiated state or expansion of a progenitor cell during retinal development (9) .
Regions of plexus with synaptic densities and synaptic vesicles were present near the outer surface of the neural retina, where the tumor initiated (Supplementary Fig. S7 ). The morphologic features of these neurites and synapses were indistinguishable from those in Chx10-Cre;Rb Lox/À ;p107 À/À tumors. When examined at high magnification (Â10,000), areas of the plexus within the posterior chamber in all three genotypes consisted of neuron-like processes with synaptic structures reminiscent of horizontal/amacrine cells. This was the case in the extensive plexus areas characteristic of Chx10-Cre; Rb Lox/À ;p107 À/À tumors and in smaller areas of plexus characteristic of p53-deficient retinae. Most processes were small (<0.5 Am in diameter), but large ones (1-3 Am) were also noted occasionally. We observed a variety of synaptic arrangements (e.g., en passon, serial, and reciprocal contacts), all of which involved contacts among processes ( Supplementary Fig. S7 ). No clear examples of axo-somatic contacts were observed. Rare instances of ribbon synapses were observed only in areas near remaining photoreceptor cell bodies. These data support the previous finding by Berns et al. that mouse retinoblastomas resemble amacrine/horizontal cells, at least during early tumorigenesis (16) . Tumor invasion and progression is accompanied by retinoblastoma cell dedifferentiation. We analyzed and compared Fig. 5A and B) . Interestingly, there were no synaptic densities or synaptic vesicles in the plexus or rosettes of the invading cells. In addition, metabolic activity was high, as indicated by their abundant mitochondria and mitotic figures ( Fig. 5A and B; data not shown). Even in rosettes with a very large central plexus, there was no evidence of cell differentiation (Fig. 5B) . In the center of the plexus were several large processes (1-3 Am), fewer small processes (<0.5 Am), and abundant mitochondria (Fig. 5B ). This suggests that rosette formation is not necessarily a feature of differentiated retinoblastoma cells, as previously believed. We found rosettes with a central plexus made up of large, undifferentiated processes and rosettes with a central plexus containing neurites and synapses. Therefore, we propose that rosettes result from junctional complexes linking adjacent somata, which is a hallmark of a wide variety of primitive neuroectodermal tumors. Eyes from Chx10-Cre;Rb Lox/À ;p107 À/À ;p53 Lox/Lox mice with anterior chamber invasion still contained differentiated tumor cells (Fig. 5C ). This finding suggests that stage I retinoblastoma cells persist during later stages of tumorigenesis. Retinoblastoma may also originate from different cells during development (e.g., one cell of origin may be a cell committed to the amacrine/horizontal cell lineage, and another may be an immature retinal progenitor cell).
Human retinoblastomas resemble late-stage mouse retinoblastomas. One advantage of studying tumorigenesis in animal models is that we can characterize the earliest stages of the disease that precede clinical diagnosis in humans. Early-stage mouse retinoblastoma is characterized by extensive cell differentiation, including neurite extension and synaptogenesis. In addition, inactivation of p53 promotes tumor progression and invasion, which is accompanied by expansion of less differentiated cells. Based on these preclinical studies, we predict that human retinoblastomas resemble stage II, less differentiated tumor phenotype. To test this hypothesis, we did TEM on seven human retinoblastomas from primary enucleations done before the patient receive any treatment.
At the light microscopic level, these tumors contained densely packed tumor cells and small plexiform regions (Fig. 6A) . One unique feature of the human retinoblastoma cells was the extensive cell-cell junctions between cell bodies (Fig. 6B ). Junctions were observed in mouse retinoblastomas ( Supplementary Fig. S8 ), but they were not as extensive along the cell body as those found in human tumors. Interestingly, there were many examples of human tumor cells invading across the ILM, and those cells were devoid of junctional complexes (Fig. 6C) . This observation raises the possibility that junctional stability is concomitantly lost during tumor cell invasion. Like mouse retinoblastoma cells invading the anterior chamber, human retinoblastoma cells contained abundant mitochondria and mitotic figures ( Fig. 6B ; data not shown) and often were organized into rosettes, which were made up of a central plexus and a surrounding row of tumor cells (Fig. 6D) . As in the mouse tumors, the human tumors contained a central plexus made up of large-and small-diameter processes, but we found no evidence for synaptic densities or synaptic vesicles in any of the seven human retinoblastomas analyzed by TEM.
Discussion
Retinoblastoma differentiation. Early-stage retinoblastoma cells undergo considerable neuronal differentiation. We use the term ''differentiation'' to indicate that retinoblastoma cells exhibited morphological and biochemical markers indicative of a commitment to a distinctive neuronal phenotype. SEM, TEM, immunostaining, Golgi-Cox staining, and molecular analyses indicated that tumor cells in our retinoblastoma models extend neurites and form synaptic connections characteristic of amacrine/ horizontal cells of the neural retina. Importantly, as the tumor progressed and invaded the anterior chamber of the eye, the cells lost these features (i.e., they still extended neurites and organized into rosettes, but they did not express proteins associated with amacrine/horizontal cell synapses, nor did they contain synaptic vesicles or form synapses). Based on these data, we propose that the loss of retinoblastoma cells' ability to differentiate is an important step in tumor progression in mice.
Human retinoblastomas resemble late-stage mouse retinoblastomas. They form rosettes and extend processes but do not form synapses. We propose that early-stage human retinoblastoma is characterized by amacrine/horizontal cell differentiation, similar to that seen in mouse tumors, but this differentiated phenotype is lost before the tumor is diagnosed. We recently presented evidence for this by showing that when the p53 pathway is inactivated in retinoblastoma cells by ectopically expressing MDMX, cells rapidly transition to a less differentiated phenotype (9) .
Retinoblastoma cell of origin. Two models that are not mutually exclusive have been proposed to explain the transition from a tumor with features of differentiated amacrine/horizontal cell neurons to one with features of less differentiated cells. First, there may be one cell of origin for this tumor, and that cell expands, The second model that explains the transition of retinoblastoma cells from differentiated to dedifferentiated cells includes two distinct cells of origin for retinoblastoma: one that is substantially more differentiated than the other. According to this model, the tumor cells that are less differentiated eventually outgrow the differentiated ones, invade the anterior chamber, and form metastatic retinoblastoma.
Synaptogenesis in retinoblastoma.
There is clear evidence for synaptic connections among retinoblastoma cells in early-stage tumors. The absence of synaptic ribbons, the relatively small size of the presynaptic terminal, and the types of postsynaptic connections suggest that these synapses arise through differentiation of a retinal interneuron phenotype, such as horizontal or amacrine cells, and not from photoreceptors or bipolar cells. The pattern of synaptic connectivity within the tumor lacks the laminar arrangement seen in normal retina but nonetheless retains one of the key elements of retinal circuitry (i.e., the general absence of axo-somatic synapses). Tumor cell bodies are excluded from plexiform regions that are densely populated with synaptic connections, among processes of varying diameters.
Based on these observations, we propose that it is unlikely that retinoblastoma synaptogenesis results from nonspecific stimulation of synapse production of remaining neurons, but rather, that it reflects a specific program of large-scale, cellular differentiation of Heterogeneity of retinoblastoma rosettes. Rosettes have been described as a histologic landmark of retinoblastoma. Some investigators have defined late-stage, differentiated tumor as a region in which 80% or more of the volume is occupied by rosettes, as determined by light microscopic analysis of H&E-stained sections. Our electron microscopy analysis showed that rosettes are heterogeneous structures, with respect to the morphology of cell bodies that constitute the outer ring and the cellular constituents of the central plexus. Stage I and II somata can form rosettes either separately or as a mixture; the plexus may contain a high density of synaptic connections or be devoid of them. It should also be noted that rosette formation, which often involves mature rod photoreceptors, occurs in almost all disruptive conditions within the retina. Therefore, this feature may simply reflect the inherent repulsive/ attractive forces between retinal somata and neurites that, under normal circumstances, produce characteristic retinal lamination.
Given their heterogeneity and nonspecificity, rosettes may have limited value in diagnosing the stage of retinoblastoma tumor progression. Alternatively, they may be correlated with disease progression because the presence of rosettes indicates strong cellcell adhesion rather than tumor cell differentiation. That is, tumors with rosettes are less aggressive because they have extensive cellcell junctions that prevent invasion. Presumably, this difference in tumor histology reflects differences in genetic lesions in pathways that control cell-cell adhesion and invasion. These processes in mouse and human retinoblastomas will be addressed in future studies.
Tumor invasion. In the mouse models of retinoblastoma, we examined how emerging tumors invade surrounding tissue. The point of tumor origin invariably involved the outer plexiform layer (OPL) and cell bodies located within the OPL or along its borders. Abnormalities in this region were observed, even when the surrounding lamina seemed unchanged. Larger tumors extended toward both the vitreal and subretinal borders, along with extensive evidence of cell death in all three nuclear layers. The Figure 6 . Human retinoblastomas resemble late-stage mouse tumors. TEM analysis was done on seven human tumors that were removed from the patient before any treatment. A, light microscopic analysis revealed that the main mass of tumor cells was infiltrated with large blood vessels. It also showed little organized structure and no recognizable retinal lamination. The major cell type had pleomorphic nuclei and limited cytoplasm, but all of the tumors contained small regions of plexus. B, in TEM images, the retinoblastoma cells were remarkably similar to those of the late-stage mouse tumors in the anterior chamber (i.e., they contained abundant mitochondria and were devoid of synaptic densities and synaptic vesicles). Both large and small processes extended from the cells, but no synaptogenesis was detected. One major difference was the extensive junctional complexes found between cells in the human retinoblastomas; mouse retinoblastoma cells were characterized by much smaller cell-cell junctions. C, tumor cells that were actively invading the retina or surrounding tissues lacked extensive junctional complexes, suggesting a possible role in invasion and metastasis. D, rosettes were organized around a central plexus, which consisted of both large and small processes but lacked synaptic densities and synaptic vesicles.
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Cancer Res 2007; 67: (6 expansive force of the tumor was obvious in SEM images of tumors with sharp protrusions into the vitreal chamber. Rupture of the ILM at the apex, which resulted from physical stress and/or enzymatic activity, provided access of tumor cells to the vitreous and a potential avenue for vitreal seeding.
Human retinoblastoma samples contain highly advanced tumors and provide limited opportunity to examine the expanding borders between tumor and normal tissue. Nevertheless, we noted several similarities with the mouse models. In one sample, the leading edge of lateral expansion of the tumor was confined to the OPL in the adjacent retina, a finding that suggests that this region in both humans and mice is involved in (or susceptible to) early stages of tumorigenesis. In another human sample, tumor cells seemed to be in transit at the point of the ILM rupture. This interpretation is based on contortion of the cell body as it filled the small opening in the ILM. The free ends of the outer limiting membrane were also extended toward the vitreous, suggesting that the movement of the tumor cell was from the retina to the vitreous, as might be envisioned during vitreal seeding.
In summary, our data support the hypothesis that early-stage human and mouse retinoblastomas exhibit features of amacrine/ horizontal cell differentiation, but these features are rapidly lost as cells become more invasive and aggressive. Although p53 does not directly regulate this process, it clearly accelerates the transition from differentiated retinoblastoma to less differentiated, invasive retinoblastoma in both humans and mice. Importantly, our observation that rosette formation does not relate to retinoblastoma tumor cell differentiation challenges the long-held belief that retinoblastomas with rosettes are less aggressive due to increased differentiation. These tumors may be less aggressive because they have extensive, stable cell-cell junctions that must be disrupted for invasion, but this does not correlate with neurite extension and synaptogenesis characteristic of early-stage retinoblastoma. This is an important distinction because it will help direct future studies toward analysis of the changes in cell-cell adhesion as retinoblastoma cells invade the optical nerve, choroids, and anterior chamber.
